Celltrion Pharm

068760.KQ

28.87 USD

-1.09

-3.64%

Overview

Last close

28.87 usd

Market cap

1.28B usd

52 week high

52.45 usd

52 week low

25.63 usd

Target price

101.47 usd

Valuation

P/E

N/A

Forward P/E

49.505

Price/Sales

6.2505

Price/Book Value

3.8475

Enterprise Value

1.32B usd

EV/Revenue

3.053

EV/EBITDA

20.6205

Key financials

Revenue TTM

204.98M usd

Gross Profit TTM

60.32M usd

EBITDA TTM

31.93M usd

Earnings per Share

N/A usd

Dividend

0.15 usd

Total assets

503.50M usd

Net debt

58.35M usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.